Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Revive Meds vs This Gen Wellness

Revive Meds
Graded #404

Level

vs
This Gen Wellness
Graded #405

Level

The verdict

Too close to call — both grade 56.9/100 (C).

Revive Meds and This Gen Wellness land on the same WeighScore, so neither clears the other on our six graded dimensions. Revive Meds sits one line higher on the board (#404 vs #405) on the underlying tiebreak, but it's a genuine coin-flip — pick on the factors and prices that matter most to you below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueThis Gen Wellness +24
21
45
Dose & formulationRevive Meds +24
64
40
Clinical oversightThis Gen Wellness +7
80
87
Labs & monitoringEven
52
52
FulfillmentRevive Meds +16
90
74
Contract termsRevive Meds +8
53
45
Revive Meds · left barThis Gen Wellness · right bar

The numbers

MetricRevive MedsThis Gen Wellness
WeighScore56.9/10056.9/100
GradeCC
Scorecard rank#404#405
Semaglutide$369/mo (starting dose, compounded)Not disclosed
Tirzepatide$459/mo (starting dose, compounded)Not disclosed
CoverageAll 50 states1 state
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Revive Meds

Graded #404 · C

Strengths

  • Offers both compounded semaglutide and dual-agonist tirzepatide, each combined with vitamin B12 (cyanocobalamin) in a single injection
  • Pay-per-order model with no subscription, sign-up fees, or long-term commitment, and free shipping on every order
  • Names its six 503A compounding pharmacies and two prescribing physicians, which is unusually transparent on fulfillment
  • Available in all 50 states and HSA/FSA eligible through a Medical Necessity Letter
  • Prepaying 3 to 12 months cuts the effective cost to as low as $202/mo (semaglutide) or $300/mo (tirzepatide)

Where it loses points

  • Month-to-month pricing is steep: $369/mo semaglutide and $459/mo tirzepatide unless you prepay several months
  • No public price list; pricing appears only after you complete a full health intake and create an account
  • Not LegitScript-certified (no seal displayed on the site)
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
This Gen Wellness

Graded #405 · C

Strengths

  • Requires a synchronous live audio-video visit with a New York-licensed clinician — prescriptions are never issued from the intake form alone
  • Assessment and clinician review are free; you only pay if treatment is prescribed and you choose to proceed
  • Names its legal entity (ThisGen, LLC) and specifies New York governing law in its terms
  • No long-term contracts — plans can be paused or stopped
  • The same clinician follows your care, with ongoing secure messaging between visits

Where it loses points

  • Publishes no prices at all — 'We don't list flat prices on the website'; cost is disclosed only after a clinician reviews your assessment
  • Serves New York only — 'we currently operate exclusively for patients located in New York'
  • Dispensing pharmacies are not named, only described as 'licensed U.S. pharmacies'
  • Does not state whether its semaglutide and tirzepatide are compounded or brand-name
  • Does not bill insurance; verifying any reimbursement is the patient's responsibility

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard